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aim was to address at which tauopathy stage neuro-inflammation starts and to study the related microglial phenotype. We used Thy1-hTau.P301S (PS) mice expressing human tau with a P301S mutation specifically in neurons. Significant levels of cortical pTAU were present from 2 months onwards. Dystrophic morphological complexity of cortical microglia arose after pTAU accumulation concomitant with increased microglial lysosomal volumes and a significant loss of homeostatic marker Tmem119. Interestingly, we detected increases in neuronal pTAU and post-synaptic structures in the lysosomes of PS microglia. Moreover, the overall cortical postsynaptic density was decreased in 6-month-old PS mice. Together, our results indicate that microglia adopt a pTAU-associated phenotype, and are morphologically and functionally distinct from wild-type microglia after neuronal pTAU accumulation has initiated.
Introduction
Intraneuronal aggregated tau inclusions, caused by tau hyperphosphorylation, are among the hallmarks of multiple neurodegenerative diseases such as Alzheimer's disease (AD), progressive supranuclear palsy and other tauopathies including frontotemporal lobar degeneration (FTLD-tau) and related frontotemporal dementia (FTD) (Spillantini & Goedert, 2013) . The development of tauopathies is a multistep process ultimately leading to neurofibrillary tangle (NFT) formation and neurodegeneration (Lee, Goedert & Trojanowski. 2001) . Familial FTLD-tau/FTD associated with tau gene MAPT mutations demonstrate that tau aberrancies alone can be sufficient to cause neurodegeneration and dementia (Spillantini & Goedert, 2013) .
Similarly, mouse models expressing human tau harboring a P301S mutation, phenocopy a number of both behavioral and pathological properties observed in familial FTLD-tau/FTD cases (Allen et al., 2002; Yoshiyama et al., 2007 & Takeuchi et al., 2011 . Neuro-inflammation is amongst these pathological properties frequently
reported, yet the exact timing and consequences remain elusive (Yoshiyama et al., 2007 & Streit et al., 2009 . Microglia are the brain-resident immune cells that constantly scan their environment and initiate phagocytosis of pathogens and debris using their highly motile processes (Nimmerjahn et al., 2005; Sierra et al. 2013) .
Accordingly, upon brain insults microglia actively adapt their shape and function (Nimmerjahn et al., 2005; Sierra et al. 2013; Fernández-Arjona et al., 2017) . The response of microglia towards pathological tau is not completely understood, as spatiotemporal data regarding microglial morphology during the tauopathy process is currently lacking. Previous literature suggests that microgliosis may precede NFT formation and could thus be considered an early manifestation associated with the tau P301S mutation (Yoshiyama et al., 2007) . Furthermore, several groups have reported microglia to be in close contact with NFTs in AD brain tissue (Cras et al, 1991; Streit et al., 2009) and, due to the phagocytic nature of microglia, they are thought to phagocytose neuronal content expressing pathological tau. This idea is partially supported by in vitro and ex vivo tau phagocytosis experiments (Luo et al., 2015 & Brelstaff et al., 2018 and findings on human isolated tau species injected in the mouse brain (Bolós et al., 2017) . However, in vivo experiments on phagocytosis of endogenously expressed neuronal pTAU in the brain are missing. Here, we describe that pTAU aggregation precedes microglial activation in the cortex of Thy1-hTau.P301S (PS) mice. The pTAU-induced microglial phenotype observed consists of morphological dystrophy, loss of homeostatic markers and lysosomal swelling. Interestingly, lysosomal swelling of PS microglia coincided with lysosomal localization of both pTAU and post-synaptic structures, together with an overall loss of cortical post-synaptic spine density.
Results/discussion
First, pTAU expression in PS and wild-type (WT) mice was assessed in a spatiotemporal manner using immunofluorescence of tau protein phosphorylation at Thr231 (PHF6) ( Fig. 1a ) and tau protein phosphorylation at Ser202 and Thr205 (AT8) ( Fig. 1b, Fig. S1 ). Both PHF6 and AT8 identify pTAU forms early in tau inclusion formation, with PHF6 as one of the first belonging to the sequential cascade of phospho-epitopes to appear during pre-tangle formation in AD (Luna-Muñoz et al, 2007) . In the cortex of PS mice, PHF6 and AT8 immunoreactivity increased significantly from 4 months onwards ( Fig. 1) , with PHF6 showing the earliest rise in signal. The pyramidal cell layer (PCL) of the hippocampal cornus ammonum and granule cell layer (GCL) of the hippocampal dentate gyrus of PS mice showed a significant albeit milder increase in PHF6+ and a slower increase in AT8+ signal from respectively 4-and 6-months forth ( Fig. 1c-d ), as reported previously (Allen et al., 2002) . As the onset of cortical pTAU preceded that of the hippocampus, we next measured the degree of cortical pTAU aggregation using total ( Fig. 2a-b ), tris-soluble ( Fig. 2c-d ) and sarkosyl-insoluble ( Fig. 2e-f ) fractions by means of western blot analysis. These data indicated that levels of tris-soluble AT8 in the cortex were robustly present from 2 months onwards and subsequently started to aggregate from 5 months onwards in PS mice.
Next, we measured the microglial response to pTAU aggregation by analyzing Iba1+ cell morphology in the cortex of PS mice using sholl analysis ( Fig. 3a ).
Different microglial morpho-phenotypes, although currently still under debate, appear to be associated with alterations in microglial activation status (Fernández-Arjona et al., 2019) . As has been previously reported by us and others, aging has a profound effect on microglia morphology (Streit et al., 2004; van Olst et al., 2018 ) and on genes expressed by microglia cells that are involved in cell adhesion, and actin (dis)assembly (Galatro et al., 2017) . Indeed, we found a significant age-related reduction in Iba1+ cell complexity from 4 months onwards in the cortex of PS mice . A significant genotype effect, however, emerged later at 5.5 months-ofage with further decreases in cortical Iba1+ complexity ( Fig. 3c ). This reduced morphological complexity at 5.5 months-of-age coincided with a smaller area occupied by cortical Iba1+ cells in PS compared to WT mice ( Fig. 3d-e ) but not by a changed number of Iba1+ cells per area ( Fig. 3f ). These data indicate that a PSinduced microglia phenotype, as measured by microglia morphological complexity, arises approximately 3.5 months after the first detection of cortical PHF6 immunoreactivity ( Fig. 1c ) and soluble AT8 levels ( Fig. 2c-d) , and 2 weeks after the occurrence of insoluble AT8 aggregation ( Fig. 2e-f ). These findings might be compatible with those from Yoshiyama et al. reporting microglial activation to precede tangles in their prion-promoter driven human tau P301S mouse model (Yoshiyama et al., 2007) , as NFT formation follows tau hyper-phosphorylation and aggregation. Our results combined with those reported by Yoshiyama et al. could imply that the timing of a microglial response to tau aberrancies occur in the final stages of early tau processing, yet before NFT formation (Yoshiyama et al., 2007) . In the hippocampal regions of PS mice, we observed a milder and slower tau pathology ( Fig. 1c-d ) together with absence of a morphological response of microglia ( Fig. S2 ).
This mild kinetic is in accordance with observations of less severe tauopathy pathogenesis in the limbic system of human FTD patients compared to other brain regions (Neary et al, 2005) and with the notion that microglia in the hippocampus are more immune vigilant (Grabert et al, 2016) .
To understand whether the aforementioned cortical PS-induced microglial phenotype could be attributed to the recently described microglial neurodegenerative phenotype (MGnD) (Krasemann et al., 2017) or disease-associated microglial phenotype (DAM) (Keren-Shaul et al., 2017), we analyzed the expression of homeostatic microglia markers P2Y12 and Tmem119 in Iba1+ cells in the cortex at 5.5 months (Fig. 4) . In accordance with a previous report (Litvinchuk et al., 2018) , our results show that cortical microglia of PS mice display significantly decreased expression levels of Tmem119 ( Fig. 4a-b ) and a non-significant reduction in P2Y12 expression ( Fig. 4c-d) . These results suggest that pTAU-induced microglial activation might be accompanied by the MGnD/DAM microglia phenotype.
We next analyzed microglial CD68 lysosome/endosome expression as a further measure for microglia activation. CD68+ volume within cortical Iba1+ cells ( Fig. 5a) was mildly, yet significantly higher in PS mice compared to WT mice at 5.5 months ( Fig. 5b ). The increase in Iba1+/CD68+ volume at 5.5 months ( Fig. 5c ) could not be explained by the unchanged number of CD68+ objects ( Fig. 5d ), but could be explained by the increased average CD68+ object volume in cortical microglia of PS mice (Fig. 5e ). These results suggest CD68+ lysosomes/endosomes to swell in cortical microglia of PS mice at 5.5 months.
We next hypothesized the lysosomal swelling to be related to microglial engulfment of both neuron-derived pTAU and synapses. Indeed, next to microglial engulfment of AT8+ neuronal structures, sequential masking of the Iba1+, CD68+ and AT8+ signal ( Fig. 5g ), revealed increases in lysosomal/endosomal pTAU content in cortical microglia of PS mice reaching significance at 5.5 months (Fig. 5h ). These in vivo results suggest that microglial engulfment of pTAU leads to lysosomemediated degradation, and complement preliminary engulfment data reported earlier from the same PS animals (Brelstaff et al., 2018) . So far, several groups have reported on the phagocytic capacity of healthy microglia upon challenge with extracellular sources of pTAU (Luo et al., 2015 , Bolos et al., 2017 . If this phagocytic capacity upholds when microglia are confronted with an aged and neuro-degenerated brain environment, is less clear. Together, our data show that endogenously expressed neuron-derived pTAU results in microglial pTAU uptake. How microglia then process and/or are affected by pTAU uptake, remains unclear. To our knowledge, we are the first to describe neuron-derived pTAU localization to microglial lysosomes of PS mice in vivo.
Interestingly, engulfed tau protein by microglia cells has been reported to enhance tau propagation throughout the brain via exosome secretion (Asai et al., 2015) . Both microglia depletion (Asai et al., 2015) and blockade of microglia proliferation (Mancuso et al., 2019) in the early stages of the pTAU cascade were able to attenuate tau pathology and reduce neurodegeneration, while microglial depletion in aged tauopathy mice appeared not to affect tau pathology (Bennet et al., 2018) . In accordance with our results, this shows that in vivo, microglia are actively involved in phagocytosis and subsequent degradation of neuron-derived pathological tau species in the early stages of tau processing.
Furthermore, we analyzed post-synaptic density levels of Homer1+ spines in the cortex of PS mice at 6 months ( Fig. 6a ). We detected a decrease in Homer1+ postsynaptic spine density in the cortex of PS mice (Fig. 6b ), which is in accordance to other studies that described synaptic loss in models of tauopathy (Hoffman et al., 2013 , Kopeikina et al., 2013 . Recently, it was reported that microglia contribute to tauopathy-related spine loss by increased engulfment of synaptic spines, (Dejanovic et al., 2018) . While the number of total contacted Homer1+ spines by Iba1+ cells remained unchanged ( Fig. 6b) , we did detect a significant increase in the number of Homer1+ post-synaptic structures in Lamp1+ lysosomes of Iba1+ cells in the cortex of PS mice (Fig. 6b ). As such, part of the decline in cortical post-synaptic spine density may be mediated by microglia that actively participate in the phagocytosis of cortical synapses upon pTAU aggregation. Additionally, we noted Lamp1+ lysosomal swelling in cortical microglia of PS mice at 6 months ( Fig. 6c ).
Microglial-mediated sculpting of neuronal circuits is critical for synaptic refinement and plasticity during development, but also plays a role in the pathogenesis of AD (Hong et al., 2016a; Hong et al., 2016b; Rajendran et al., 2018) .
Different mediators, such as those of the complement system, control this synaptic removal (Stevens et al., 2007; Schafer et al., 2012; Stephan et al., 2012; Bialas et al., 2013) . Interestingly, genes related to complement activation are differentially expressed in the CNS of young tauopathy mice and complement itself has been found to localize to neuronal pTAU (Ke et al., 2019) . Together with our findings, these reports underline microglia to be actively involved in spine elimination and suggest that microglia actively reshape synapses in a tauopathy-induced neurodegenerative environment.
In conclusion, our results illustrate microglia to actively respond to neuronal pTAU aggregation in the early stages of tau processing. This microglial response 
Materials and methods

Animals, tissue processing and immunohistochemistry
Non-transgenic CBAxC57BL6 mice and homozygous Thy1-hTAU.P301S mice (Allen et al., 2002) in a CBAxC57BL6 background were maintained at the reMYND NV center (Leuven, Belgium). reMYND's accreditation number is LA1210532 and the number of the protocol approved by the Ethical Committee is 161103.R01. Mice were kept in cages with 12-hour light/dark cycles and food and water was available ad libitum. For the different experiments, groups of mice (n ≥ 5 per group) were sacrificed at 2, 3, 4, 4.5, 5, 5.5 and 6 months of age. To do so, mice were anaesthetized with ketamine, xylazin 2%, atropine and saline (4:2.5:1:2.5).
Temperature was monitored with a rectal thermometer and body temperature was maintained accordingly using a heating blanket. Once the body cavity was opened, the left ventricle was punctured for trans-cardial perfusion with a peristaltic pump and ice-cold saline for three minutes (3 ml/min). Simultaneously, the right atrium was cut to allow excess of liquid to escape. Next, the head was removed from the body and the brains were isolated from the skull. From here on, all tissues were randomized and samples were blinded. From every brain, the left hemisphere was post-fixed with 4% paraformaldehyde in PBS and processed for western blotting as described in the respective section. The right hemisphere was post-fixed overnight (4% PFA in PBS, 4°C) and stored in PBS with 0.1% (v/w) sodium azide (4°C) before sectioning. More specifically, per mouse, 40 µm thick sections at intervals of 160 µm were collected using a vibratome (VT1200, Leica) and stored in PBS at 4°C for immunohistochemical analysis. For immunohistochemistry the following primary ( Table 2 . Secondary antibodies used.
Microscopy and morphological Analysis
Immunostained brain sections were imaged using either a Zeiss imager D2 fluorescent microscope, a Nikon A1R confocal microscope or a Leica TCS SP8 HyD confocal microscope. For pTAU coverage, the thresholded AT8 and PHF6 signals were measured in the cortex and in the pyramidal cell layer (PCL) of the hippocampal cornus ammonum and granule cell layer (GCL) of the hippocampal dentate gyrus.
using ImageJ and expressed as a relative surface area percentage of total surface. Per animal, all values were averaged from 10-20 analyzed images.
For engulfment of Homer1+ spines by Iba1+ cells, Kiss and Run XT analysis was performed in batch to create a new channel that displayed the distance between each Homer1+ spot and the Iba1+ and Lamp1+ volumes. Since Lamp1 is a general lysosomal marker that is not specific for microglia, created Lamp1 volumes that were negative for Iba1 expression were excluded. Iba1+Homer1+ spots in direct contact with microglia processes and completely internalized Lamp1+Iba1+Homer1+ spots were selected and analyzed using the newly created distance-transformed channel by setting the distance-threshold between each spot and surface-of-interest to 0 µm.
Finally, the interaction of microglia with Homer1+ synaptic terminals was calculated by dividing the number of contacted/internalized Iba1+Homer1+ spots and the number of totally engulfed Lamp1+Iba1+Homer1+ spots by the total volume of the imaged section ((x * y * 0.3 µm * 20 z-slices) -DAPI volume). Relative lysosomal volume of Lamp1 (%) was calculated by dividing the total Lamp1 volume by the total microglial volume per image. Again, per animal, all values were averaged from 10-20 analyzed images.
Homogenization and differential extraction for western blot analyses
Differential extraction was performed after homogenizing the cortex with a pottertype mechanical homogenizer (VOS 14 S40, rate: 750 rpm; VWR) in 9 weightvolumes of ice-cold homogenization buffer, containing 20 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM ethylene diamine tetra acetic acid (EDTA, Merck), 1 mM ethylene glycol tetra acetic acid (EGTA, Sigma-Aldrich), 10 mM 1,10-orthophenanthrolinemonohydrate (Sigma-Aldrich), a cocktail of proteinase inhibitors (CompleteTM, Roche, Germany), halt protease and phosphatase inhibitor (at a 2x concentration, Thermo Scientific, Belgium) and deacetylase inhibitors Trichostatin (1 µM, Sigma-Aldrich) and nicotinamide (5 mM, Sigma-Aldrich). A fixed volume of approximately half of the total homogenates (TotH) was centrifuged (136000xg, 60 min, 4°C; TLA-55 rotor, Optima TLX Ultracentrifuge, Beckman Coulter) to generate a Tris-soluble fraction (SF), while the remainder was stored at -80°C. The supernatant (S1, further referred to as soluble fraction or SF) was separated from the pellet (P1), and stored at -80°C. The pellet (P1) was solubilized in 9 weight-volumes high-salt (0.85 M NaCl) containing homogenization-buffer. This fraction was centrifuged (20000xg, 30 min, 4˚C) and the resulting high-salt pellet (P2) was stored at -80˚C.
The supernatant (S2) was brought to 1% Sarkosyl with 10% Sarkosyl and incubated at room temperature for 60 min in a thermomixer (at room temperature) and then centrifuged (136000 x g, 60 min, 4˚C). The supernatant (S3, further referred to as Sarkosyl-soluble fraction or SSF) was stored at -80˚C. The pellet (P3) was resuspended in homogenization buffer (2µl per mg tissue) and stored at -80°C (further referred to as insoluble fraction or IF). or SuperSignal West Femto Maximum Sensitivity Substrate, Thermo Scientific) and
Poly-acrylamide gel electrophoreses and Western blotting
images were recorded digitally (VisionWorks Acquisition, UVP) with different exposure times. Dedicated software (VisionWorks Analysis, UVP) was used for analysis of the blots.
All TotH and SF blots were re-probed with anti-NSE (Abcam Ab16807; dilution 1:1000) as loading control. Samples were run in duplicate. For IF no suitable loading control is known. As multiple gels will be used for each antibody, reference samples of either TotH or SF fractions were run on each gel as an inter-gel reference. For the IF fractions, also TotH reference material was used on each gel.
Statistical Analysis
All data reflect mean±SEM and all comparisons were statistically tested in GraphPad Prism 8.2.1. using either unpaired two-tailed Student's t-tests for comparing two experimental groups, or two-way analysis of variance (ANOVA) test when more than two groups were compared. With these statistical tests significant differences are indicated and reflect the following p-values: *p<0.05, **p<0.01 and ***p<0.001.
Sholl analysis curves from which area under the curve data were deduced, were created and analyzed using GraphPad Prism 8.2.1. (g) Plots displaying the relative AT8+ volume within the Iba1+/CD68+ masked region of interest.
Figure legends
Significant differences from two-way ANOVA (b and h) and Student's t-test (c, d and e) are indicated *p<0.05, **p<0.01, ***p<0.001, (genotype effect within age group).
Scale bars=20 µm (a and f) and 4 µm (f'). N=5-6 per genotype. (a) Sholl plots displaying Iba1+ cell branch intersections at 5.5 months from hippocampal (dentate gyrus) brain regions per 2 µm steps from the cell soma. 
